Disease
|
Drug/Important Bio-Agent (IBA)
1 | Indicators and Reagents (Reagents)IBA
12/2023 |
1 | Calcineurin InhibitorsIBA
01/2023 |
1 | delgocitinibIBA
01/2023 |
1 | pimecrolimus (Elidel)FDA Link
01/2023 |
1 | crisaboroleIBA
01/2023 |
1 | SteroidsIBA
01/2023 |
1 | Tacrolimus (Prograf)FDA LinkGeneric
01/2023 |
1 | Adrenal Cortex Hormones (Corticosteroids)IBA
01/2020 |
1 | Phosphotransferases (Kinase)IBA
04/2014 |
1 | 2- hydroxy- 1- (2- ((9- (4- methylcyclohexyl)- 9H- pyrido(4',3'- 4,5)pyrrolo(2,3- d)pyrimidin- 2- yl)amino)- 7,8- dihydro- 1,6- naphthyridin- 6(5H)- yl)ethanoneIBA
04/2014 |
1 | (2S,3R,4R,5S,6R)- 2- (4- chloro- 3- (4- ethoxybenzyl)phenyl)- 6- (methylthio)tetrahydro- 2H- pyran- 3,4,5- triolIBA
05/2013 |
1 | Peptide YYIBA
05/2013 |
1 | Glucagon-Like Peptide 1 (GLP 1)IBA
05/2013 |
1 | AntibodiesIBA
05/2009 |
|
Therapy/Procedure
|